semaglutide and asthma medication Is Ozempic the New Anti-Inflammatory Wonder Drug? obesitycare #weightmanagement #semaglutide #pharmanews #indiahealthcare

GLP-1 is the hormone targeted by Ozempic to reduce appetite and promote satiety

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

PriorityYou Health Center offers in-office visits for Clinical Weight Loss, Bio-identical Hormone Replacement Therapy for Men and Women, IV Hydration in Jasper Indiana

This delicious treat helps clean your teeth and enjoy a healthy smile and leave you with fresh, minty breath

Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses.

Available for both RF and RM licensing.